Skip to content
Screener

Total Current Assets at other companies

Merck & Co. logo
Merck & Co.MRK
$36.68B-1.0%
Savara logo
SavaraSVRA
$209.27M+17.9%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$667M-24.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$417.63M+178%
LQD
Liquidia CorporationLQDA
$333.06M+87.9%
United Therapeutics logo
United TherapeuticsUTHR
$3.48B-9.0%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.63B+197%
Enterprise value$2.61B+239%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206390
AssetsMarch 31,2026 / UnauditedDecember 31,2025
Marketable securities152,371169,346
Prepaid expenses2,2161,263
Other current assets2,1222,133
Total current assets176,121191,656
Operating lease right-of-use assets610677
Property, equipment and leasehold improvements, net265178
Other non-current assets2,610928
Total assets$179,606$193,439

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is Trevi Therapeutics, Inc.'s total current assets?
Trevi Therapeutics, Inc. (TRVI) reported total current assets of $176.12M in Q1 2026.
How has Trevi Therapeutics, Inc.'s total current assets changed year-over-year?
Trevi Therapeutics, Inc.'s total current assets increased by 66.7% year-over-year, from $105.62M to $176.12M.
What is the long-term trend for Trevi Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s total current assets has grown at a 32.9% compound annual growth rate (CAGR), from $46.27M to $191.66M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Trevi Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude